Table 2.
Sample | FOS | Ad-FOS | RMD | MOS | |
---|---|---|---|---|---|
Reducing sugar contents (△%*) | Oral | 0.11 | 0.08 | 0.42 | 2.33 |
Gastric | 0.64 | 0.25 | 0.34 | 0.95 | |
Intestinal | 0.01 | 0.4 | 0.51 | 2.78 | |
BBMV | 0.72 | 0.96 | 6.45 | 7.66 | |
Total** | 1.49 | 1.69 | 7.71 | 17.55 | |
Glucose (or fructose) contents (△%) | Oral | -*** | - | 0.31 | 0.2 |
Gastric | 0.37 | 0.18 | 0.22 | 0.17 | |
Intestinal | - | - | 0.42 | 2.4 | |
BBMV | - | - | 2.12 | 7.62 | |
Total | 0.37 | 0.18 | 5.74 | 10.3 |
Changes in reducing sugar and glucose (or fructose) contents were calculated as (each content after digestion)—(each content before digestion).
Total values were calculated as (total increment of reducing sugar and glucose (or fructose) content/initial sample weight) ×100
‘-’ means that there was no detection using HPLC analysis.